Reporter Staff

Reporter Staff

| This email address is being protected from spambots. You need JavaScript enabled to view it.
UAB researchers are looking for adults (ages 25-65) who are suffering from demoralization - feelings of hopelessness or meaninglessness - to participate in a research study evaluating a novel medication.

To see if you qualify call 205-379-7527.

The new draft strategic plan will be shared Oct. 25 to solicit feedback from the campus community before it is finalized and presented to the UA System Board of Trustees.

With fall semester already in high gear, here is a quick refresher on all that the UAB Career Center offers to support students on their career journeys.

If the answer to all of these questions is YES, you could be eligible to participate in a research study examining the impact of gender identity, hormone levels and sex assigned at birth to pain sensitivity in people who have chronic low back pain. – the ERASED study (Racial and Socioeconomic Differences in Chronic Low Back Pain).

The commitment to this study is two visits that will last approximately 4-5 hours and include:

  • One (1) telephone screen
  • Two (2) visits to UAB where you will fill out questionnaires, have a single blood draw, take part in pain sensitivity and functional testing.

If you are eligible to participate in this study, you will receive up to $400.

Participants must:
  • Identify as transgender
  • Be between 18 and 85 years of age
  • Have none of the following health conditions (HIV+, cardiovascular disease, uncontrolled hypertension)

Participants can be on HRT (hormone replacement therapy) or not.

To find out more about this study, call 205-934-8743. For information regarding research studies and rights of participants, call 205-834-3625.

UAB experts encourage healthy behaviors, responsible symptom management and vaccines to avoid and manage respiratory illnesses like COVID, common cold, RSV or the flu. 
Revisiting the successes in patient care achieved together through UAB’s current strategic plan.

Revisiting the successes in community engagement achieved together through UAB’s current strategic plan.

Revisiting the research successes achieved together through UAB’s current strategic plan.

Revisiting the academic successes achieved together through UAB’s current strategic plan.

CURB-2 is an abbreviation we use to refer to this study because there was a similar study completed and published in 2016 called CURB, which stands for Cocaine Use Reduction with Buprenorphine. The results from that study showed that using injectable naltrexone and sublingual buprenorphine was beneficial to participants on high doses of the medication. This study will give injectable naltrexone and injectable buprenorphine to make sure medication doses are consistent to confirm potential benefits.

There are no approved treatments specifically for cocaine use disorder. We are looking for adults (18-65 years of age) who are using cocaine and who are interested in reducing or stopping their use. The purpose of our study is to test a combination of two medications for 2 months as a possible treatment for cocaine use disorder.

This study includes the use of a placebo, which looks like the medication we are testing but does not include any active medicine. Study medication and assessments will be provided to participants at no cost. Participants will receive compensation for their time and efforts.

Study information will be kept strictly confidential. Your privacy is important to us.

Call us for more information at 205-996-0211 or email us at
Page 9 of 66